arrow
B

Bryan J. Neth

Mayo Clinic
H指数:17
被引数:2,390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice

神经肿瘤学实践中脑脊液游离DNA分子分型的初步经验

2026-10-030
OA
SUPC-01 USE OF THE SELECTIVE PLASMA KALLIKREIN INHIBITOR RZ402 FOR STABILIZATION OF CEREBRAL EDEMA RELATED TO METASTATIC MELANOMA – RESULTS OF A SINGLE PATIENT PROTOCOL

SUPC-01 选择性血浆激肽释放酶抑制剂RZ402用于稳定与转移性黑色素瘤相关的脑水肿——单患者方案的结果

2026-08-070
OA
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

ivosidenib在主要复发性IDH1突变型胶质瘤中的应用:一项单机构经验

2026-05-010
PRE
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiation

神经肿瘤学远程认知评估方案:部署梅奥诊所的远程认知评估测试套件和可穿戴设备监测平台,同时评估二甲双胍对有颅脑放射治疗史患者认知功能和生命质量的影响

2026-05-010
OAAI
Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans

作者更正:食用改良的地中海生酮饮食可逆转人类阿尔茨海默病的外周脂质特征

2026-04-060
OAAI
Establishing an Alzheimer Disease Therapeutics Clinic: Experience From a Year of Evaluations
2026-01-230
PRE
Protocol for neuro-oncology anywhere 242: Pilot study evaluating telehealth and in-person assessments in patients with glioma receiving oral chemotherapy

神经肿瘤学 Everywhere 242 项目方案:评估接受口服化疗的胶质瘤患者中远程医疗与面对面评估的试点研究

2026-01-010
OAAI
Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice
2025-12-010
PRE
Pembrolizumab efficacy in recurrent adult-type diffuse gliomas

帕博利珠单抗在复发成人型弥漫性胶质瘤中的疗效

2025-11-010
OAAI
Neuro-oncology anywhere (NOA) 242: Interim results from a pragmatic clinical trial evaluating telehealth versus in-person evaluations for individuals with glioma undergoing oral chemotherapy

神经肿瘤学无处不在(NOA)242:一项实用型临床试验的初步结果,评估远程医疗与面对面评估对于接受口服化疗的胶质瘤患者的影响

2025-11-010
OAAI
Clinical utility of RANO 2.0 for response assessment to immunotherapy in recurrent gliomas

RANO 2.0在复发性胶质瘤免疫治疗反应评估中的临床应用价值

2025-11-010
PRE
Neuro-oncology anywhere: A fully decentralized clinical trial evaluating cognitive assessments and interventions for patients who received intracranial radiation therapy

神经肿瘤学无处不在:一项完全去中心化的临床试验,评估接受颅内放射治疗患者的认知评估和干预措施

2025-11-010
OAAI
WSD0922-FU THERAPY IN PATIENTS WITH EGFR MUTANT GLIOBLASTOMA - UPDATES FROM THE DOSE EXPANSION COHORTS OF A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL (MC1914)

WSD0922-FU疗法在EGFR突变型胶质母细胞瘤患者中的应用——来自一项首次人体I期临床试验(MC1914)剂量扩展队列的更新信息

2025-11-010
OAAI
The risk for cognitive impairment differs in male and female cancer survivors

认知障碍的风险在男性和女性癌症幸存者之间存在差异。

2025-11-010
OAAI
RELATIONSHIPS BETWEEN LYMPHOCYTE COUNTS AND CLINICAL OUTCOMES IN PATIENTS WITH GLIOMAS TREATED WITH PEMBROLIZUMAB

胶质瘤患者接受帕博利珠单抗治疗后淋巴细胞计数与临床结局的关系

2025-11-010
OAAI
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis

表征成人中线胶质瘤的分子和空间异质性: 单一机构分析

2025-03-010
PRE